Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection

NCT05787938 | Unknown

• 1 other identifier: MRI in urinary bladder tumors
• Study Type: observational
• Target: 58
• Locations: 0 countries
• Sites: N/A

Brief Summary

To study the feasibility of using magnetic resonance imaging (MRI) in evaluation UB wall thickening after transurethral resection (TUR) of bladder cancer.

Conditions

Urinary Bladder Cancer

Outcome Measures

Primary Outcomes (1)

• The Role of Magnetic Resonance Imaging (MRI) in assessment of the urinary bladder wall transurethral tumor resection.

  To study the feasibility of using magnetic resonance imaging (MRI) in evaluation UB wall thickening after transurethral resection (TUR) of bladder cancer.

  Baseline

Interventions

MRI DEVICE

A procedure that uses radio waves, a powerful magnet, and a computer to make a series of detailed pictures of areas inside the body. A contrast agent, such as gadolinium, may be injected into a vein to help the tissues and organs show up more clearly in the picture. MRI may be used to help diagnose disease, plan treatment, or find out how well treatment is working. It is especially useful for imaging the brain and spinal cord, the heart and blood vessels, the bones, joints, and other soft tissues, the organs in the pelvis and abdomen, and the breast. Also called magnetic resonance imaging, NMRI, and nuclear magnetic resonance imaging.

Eligibility Criteria

• Age: 40 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who had a history of TUR of superficial bladder tumors. mainly in older people over the age of 55. most common in men, but it's less common in women.

You may qualify if:

• Patients who had a history of TUR of superficial bladder tumors and fit for the MRI examination.

You may not qualify if:

• Patients with pacemaker, claustrophobia or metallic prosthesis which are not MRI compatible.
• Patients with contraindications for cystoscopy (unfit for anesthesia or urethral stricture).
• Patients refusing consent for the study.

Sponsors & Collaborators

• Assiut University: lead

Related Publications (5)

• El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. BJU Int. 2012 Dec;110(11 Pt B):E622-7. doi: 10.1111/j.1464-410X.2012.11345.x. Epub 2012 Jul 3.

  PMID: 22757606 BACKGROUND

• Wang Y, Zhang W, Xiao W, Chen S, Wei Y, Luo M. Feasibility of Early Evaluation for the Recurrence of Bladder Cancer after Trans-Urethral Resection: A Comparison between Magnetic Resonance Imaging and Multidetector Computed Tomography. Tomography. 2022 Dec 22;9(1):25-35. doi: 10.3390/tomography9010003.

  PMID: 36648990 BACKGROUND

• Webb JA. Imaging in haematuria. Clin Radiol. 1997 Mar;52(3):167-71. doi: 10.1016/s0009-9260(97)80269-3. No abstract available.

  PMID: 9091250 BACKGROUND

• Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988 Aug;168(2):497-505. doi: 10.1148/radiology.168.2.3393671.

  PMID: 3393671 BACKGROUND

• Dobson MJ, Carrington BM, Collins CD, Ryder WD, Read G, Hutchinson CE, Hawnaur JM. The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol. 2001 Feb;56(2):94-8. doi: 10.1053/crad.2000.0560.

  PMID: 11222064 BACKGROUND

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Urologic Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Urinary Bladder Diseases; Urologic Diseases; Male Urogenital Diseases

Study Officials

• Amr Farouk Muorad, Prof.Doctor

  Assiut University

  PRINCIPAL INVESTIGATOR

• Mohamed Moamen Elbaroudy, doctor

  Assiut University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ayat Ibrahim, Resident Doctor

CONTACT

01068306016; ayatibrahim59@yahoo.com

Samy Abdelaziz, Prof.Doctor

CONTACT

01006788053

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Doctor

Study Record Dates

• First Submitted: March 15, 2023
• First Posted: March 28, 2023
• Study Start: April 1, 2023
• Primary Completion: April 1, 2024
• Study Completion: December 1, 2024
• Last Updated: March 28, 2023

Record last verified: 2023-03